A Clinical Trial of Psychodynamic-Interactional and Body Therapy in Somatoform Pain Disorders - Positive Interpersonal Experiences for Patients with Early Trauma.
Eva Neumann, Silke Michalek, Markus Pressentin, Stefanie Hölscher, Marion Grässner, Jörg Rademacher
{"title":"A Clinical Trial of Psychodynamic-Interactional and Body Therapy in Somatoform Pain Disorders - Positive Interpersonal Experiences for Patients with Early Trauma.","authors":"Eva Neumann, Silke Michalek, Markus Pressentin, Stefanie Hölscher, Marion Grässner, Jörg Rademacher","doi":"10.13109/zptm.2023.69.3.278","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objectives:</b> The aim of this clinical trial was to explore whether psychodynamic-interactional therapy leads to a better outcome in the treatment of somatoform pain disorders when combined with body therapy. <b>Methods:</b> 30 patients diagnosed with this disorder took part in outpatient group therapies with 25 sessions. In the intervention condition, sessions based on psychodynamic-interactional and body therapy took place in weekly change, while in the control condition all sessions were based on psychodynamic-interactional therapy. Data were collected with self-report measures at the beginning and end of therapy and at the 6-months follow-up. <b>Results:</b> Under both conditions somatic and psychological symptoms merely remained stable from the first to the third measurement time. However, patients expressed a high level of satisfaction with the relationships in the group. <b>Conclusions:</b> Contrary to the assumptions, the two therapy conditions did not differ in the treatment outcome. Both conditions proved successful in providing patients with supporting interpersonal experiences.</p>","PeriodicalId":51217,"journal":{"name":"Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie","volume":"69 3","pages":"278-292"},"PeriodicalIF":0.8000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.13109/zptm.2023.69.3.278","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: The aim of this clinical trial was to explore whether psychodynamic-interactional therapy leads to a better outcome in the treatment of somatoform pain disorders when combined with body therapy. Methods: 30 patients diagnosed with this disorder took part in outpatient group therapies with 25 sessions. In the intervention condition, sessions based on psychodynamic-interactional and body therapy took place in weekly change, while in the control condition all sessions were based on psychodynamic-interactional therapy. Data were collected with self-report measures at the beginning and end of therapy and at the 6-months follow-up. Results: Under both conditions somatic and psychological symptoms merely remained stable from the first to the third measurement time. However, patients expressed a high level of satisfaction with the relationships in the group. Conclusions: Contrary to the assumptions, the two therapy conditions did not differ in the treatment outcome. Both conditions proved successful in providing patients with supporting interpersonal experiences.
期刊介绍:
This journal provides a systematic overview of the entire field of psychosomatic medicine. It is also the official organ of the German Society for Psychosomatic Medicine and Medical Psychotherapy (DGPM). It serves as a forum for discussions of the interdisciplinary experiences in the field of psychosomatics, the goal being the furtherance of scientific insights into the interactions between mental and physical factors in the development of disease. It also provides a way to deepen one´s knowledge of psychoanalysis and to explore new therapeutic directions.